NO803176L - Analogifremgangsmaate for fremstilling av farmakologisk aktl ive aminopropanolderivater av 5-(2-hydroksystyryl)-isoksazo - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktl ive aminopropanolderivater av 5-(2-hydroksystyryl)-isoksazo

Info

Publication number
NO803176L
NO803176L NO803176A NO803176A NO803176L NO 803176 L NO803176 L NO 803176L NO 803176 A NO803176 A NO 803176A NO 803176 A NO803176 A NO 803176A NO 803176 L NO803176 L NO 803176L
Authority
NO
Norway
Prior art keywords
hydroxystyryl
preparation
derivatives
isocsazo
aminopropanole
Prior art date
Application number
NO803176A
Other languages
English (en)
Norwegian (no)
Inventor
Fritz-Frieder Frickel
Peter C Thieme
Albrecht Franke
Hans Theobald
Dieter Lenke
Josef Gries
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO803176L publication Critical patent/NO803176L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/03Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04Saturated ethers
    • C07C43/12Saturated ethers containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/64Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO803176A 1979-10-26 1980-10-24 Analogifremgangsmaate for fremstilling av farmakologisk aktl ive aminopropanolderivater av 5-(2-hydroksystyryl)-isoksazo NO803176L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792943405 DE2943405A1 (de) 1979-10-26 1979-10-26 Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols

Publications (1)

Publication Number Publication Date
NO803176L true NO803176L (no) 1981-04-27

Family

ID=6084497

Family Applications (1)

Application Number Title Priority Date Filing Date
NO803176A NO803176L (no) 1979-10-26 1980-10-24 Analogifremgangsmaate for fremstilling av farmakologisk aktl ive aminopropanolderivater av 5-(2-hydroksystyryl)-isoksazo

Country Status (13)

Country Link
US (1) US4305951A (da)
EP (1) EP0027978B1 (da)
JP (1) JPS5673076A (da)
AT (1) ATE2145T1 (da)
AU (1) AU532983B2 (da)
CA (1) CA1157476A (da)
DE (2) DE2943405A1 (da)
DK (1) DK449680A (da)
ES (1) ES496240A0 (da)
IE (1) IE50797B1 (da)
IL (1) IL61274A (da)
NO (1) NO803176L (da)
ZA (1) ZA806555B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69425882T2 (de) * 1993-03-29 2001-01-11 Basf Ag 1-amino-3-phenoxy-propan-derivate als modulatoren bei multi-drug resistenz
CA2258556A1 (en) * 1996-06-17 1997-12-24 Julian Stanley Kroin Drug resistance and multidrug resistance modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH451115A (de) 1964-09-10 1968-05-15 Ciba Geigy Verfahren zur Herstellung eines neuen Amins
CA945172A (en) 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
BE754405A (fr) * 1969-08-05 1971-02-04 Thomae Gmbh Dr K Nouveaux beta-aryl-2-aminoalcoxystyrenes
US3624079A (en) * 1969-10-20 1971-11-30 Upjohn Co 5-(phenylstryl)-3methylisoxazoles
DE2549962A1 (de) * 1975-11-07 1977-05-18 Basf Ag Neue isoxazole und verfahren zu ihrer herstellung
DE2624918A1 (de) 1976-06-03 1977-12-15 Thomae Gmbh Dr K Arzneimittel mit antiarrhythmischer wirkung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen

Also Published As

Publication number Publication date
ATE2145T1 (de) 1983-01-15
IL61274A0 (en) 1980-12-31
US4305951A (en) 1981-12-15
ES8106895A1 (es) 1981-09-16
DK449680A (da) 1981-04-27
DE3061518D1 (en) 1983-02-03
DE2943405A1 (de) 1981-05-07
AU6366780A (en) 1981-04-30
EP0027978B1 (de) 1982-12-29
CA1157476A (en) 1983-11-22
ZA806555B (en) 1981-11-25
JPS5673076A (en) 1981-06-17
IE802191L (en) 1981-04-26
AU532983B2 (en) 1983-10-20
IL61274A (en) 1984-04-30
ES496240A0 (es) 1981-09-16
EP0027978A1 (de) 1981-05-06
IE50797B1 (en) 1986-07-23

Similar Documents

Publication Publication Date Title
NO150361C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-(1h-tetrazol-5-yl)-4h-(pyrido-(1,2-a)-pyrimidin-4-on-derivater
NO155774C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazo-diazepin-derivater.
NO170803C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater samt forbindelser til bruk ved fremgangsmaaten
NO150760C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler.
NO166184C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n9-cyklopentyl-substituerte adeninderivater.
NO151287C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-hydrazono-6,7,8,9-tetrahydro-4h-pyrido(1,2-a)-pyrimidinderivater
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
NO155244C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer fra deres tilsvarende nitriler.
NO146599C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav
NO810480L (no) Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
NO160370C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive penam-1,1-dioksyd-forbindelser.
NO153137C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte pyrido(1,2-a)pyrimidiner.
AU532983B2 (en) 5-(2-hydroxystyryl)-isoxazole derivatives
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
NO152843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidopyrimidiner.
NO147563C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-(2-furoyl-, 5-(2-tenoyl)-, 5-(3-furoyl)- og 5-(3-tenoyl)-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater
DK162738C (da) Varmesteriliserbart kunstigt organ til blodrensning
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
JPS5636483A (en) 66imidazolyll33hydrazinoopyridazine* its manufacture and medicine containing it
ES480045A1 (es) Procedimiento para la obtencion de derivados amino del 2-me-til-5-2-hidroxiestiril-1,3,4-tiadiazol.
NO152788C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperazinylbenzoheterocykliske forbindelser.
NO152650C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prolinderivater.
NO147069C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-difluor-methyl-6,7-methylendioxy-1,4-dihydro-4-oxo-3-kinolincarboxylsyre og derivater derav
IE780207L (en) 4-hydroxy-1,2-benzisothiazole